Back

SCF-FBXW7 regulates G2-M progression through control of CCNL1 ubiquitination

O'Brien, S.; Kelso, S.; Steinhart, Z.; Orlicky, S.; Mis, M.; Kim, Y.; Lin, S.; Sicheri, F.; Angers, S.

2022-09-26 cancer biology
10.1101/2022.09.26.509608 bioRxiv
Show abstract

FBXW7, which encodes a substrate specific receptor of an SCF E3 ligase complex, is a frequently mutated human tumor suppressor gene known to regulate the post-translational stability of various proteins involved in cellular proliferation. Here, using genome-wide CRISPR screens we report a novel synthetic lethal genetic interaction between FBXW7 and CCNL1 and describe CCNL1 as a new substrate of the SCF-FBXW7 E3 ligase. Further analysis showed that the CCNL1-CDK11 complex is critical at the G2-M phase of the cell cycle since defective CCNL1 accumulation, resulting from FBXW7 mutation, leads to shorter mitotic time. Cells harboring FBXW7 loss-of-function mutations are hypersensitive to treatment with a CDK11 inhibitor, highlighting a genetic vulnerability that could be leveraged for cancer treatment.

Published in The EMBO Reports · not in our set (fewer than 10 published preprints to learn from) · training set

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.